As of September 2024, Genovate Biotechnology has a market cap of $75.78M. This makes Genovate Biotechnology the world's 22785th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $86.54M | -4.70% |
2023 | $90.80M | -18.15% |
2022 | $110.94M | 31.05% |
2021 | $84.66M | -15.11% |
2020 | $99.73M | 21.34% |
2019 | $82.19M | -7.22% |
2018 | $88.59M | -16.74% |
2017 | $106.40M | -15.30% |
2016 | $125.62M | -40.44% |
2015 | $210.93M | -1.46% |
2014 | $214.05M | 77.91% |
2013 | $120.31M | -20.21% |
2012 | $150.78M | 379.97% |
2011 | $31.41M | 0.00% |
2010 | $31.41M | 0.00% |
2009 | $31.41M | 13.50% |
2008 | $27.68M | -33.74% |
2007 | $41.77M | - |